ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BLND
Blend Labs, Inc.
BLND has the edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BLND Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Unavailable |
BLND's cash flow is currently healthy, and its revenue is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
BLND PE Valuation
BLND has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BLND Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BLND's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
BLND has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus BLND down 116%.
BLND Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.04 | — |
| Q3 2024 | -$0.33 | +$0.64 |
| Q2 2024 | -$0.48 | +$0.88 |
| Q1 2024 | -$0.57 | +$2.67 |
| Q4 2023 | -$0.76 | +$2.52 |
BLND is still losing money, but far less than before: $0.09 per share over the past year, against $3.28 at its worst in late 2022.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over BLND on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
BLND Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | +0.2% |
| Q2 2026 | $33.8M | +7.3% |
| Q1 2026 | $30.8M | +15% |
| Q4 2025 | $32.4M | -22% |
| Q3 2025 | $32.9M | -27% |
| Q2 2025 | $31.5M | -22% |
| Q1 2025 | $26.8M | -23% |
| Q4 2024 | $41.4M | +15% |
BLND's revenue fell from its 2021 peak and has held roughly level since: $33M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8% | +6.9 points |
| Q2 2026 | -4.7% | +10 points |
| Q1 2026 | -16% | +12 points |
| Q4 2025 | -11% | -6.7 points |
| Q3 2025 | -15% | +15 points |
| Q2 2025 | -15% | +18 points |
| Q1 2025 | -29% | +32 points |
| Q4 2024 | -4.3% | +56 points |
BLND has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
BLND Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $94K | +$5.9M |
| Q2 2026 | $7.1M | +$17.2M |
| Q1 2026 | $6.2M | -61% |
| Q4 2025 | -$21K | +$7.1M |
| Q3 2025 | -$5.8M | -$4.4M |
| Q2 2025 | -$10.1M | -$1.6M |
| Q1 2025 | $15.8M | +$21.6M |
| Q4 2024 | -$7.2M | +$13.6M |
BLND has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
BLND Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7.2% | -18.3M shares |
| 1 year | -8.4% | -21.9M shares |
| 3 years | -2.8% | -6.9M shares |
| 5 years | +8.1% | +17.7M shares |
| Available history | +8.1% | +17.7M shares |
BLND has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $20.4M |
| Q1 2026 | $16.8M |
| Q4 2025 | $15.7M |
| Q3 2025 | $5M |
| Q2 2025 | $1.6M |
| Q1 2025 | $2.6M |
| Q4 2021 | $110,000 |
BLND spent $53M buying back its own shares over the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BLND Net Leverage
BLND's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
BLND Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 19.4 | Oversold |
BLND's weekly RSI is 38 (neutral) and its Stochastic is 19 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
BLND PE vs Technology Sector
BLND has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
BLND Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.05 | 1.9% above |
| 20 week MA | $1.37 | 22% below |
| 50 week MA | $1.77 | 40% below |
| 100 week MA | $2.63 | 59% below |
| 200 week MA | $2.44 | 56% below |
BLND has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 56% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over BLND on returns for 2026, with the stronger performance.
BLND Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.9 | $7.53 | -64% |
| 2022 | $7.53 | $1.22 | -84% |
| 2023 | $1.22 | $2.55 | +109% |
| 2024 | $2.55 | $4.29 | +68% |
| 2025 | $4.29 | $3.05 | -29% |
| 2026 YTD | $3.05 | $1.07 | -65% |
BLND's yearly returns have swung widely, from +109% in 2023 to −84% in 2022. It's down 65% so far in 2026.